Sky Century Investment (SKYI) Interest Coverage Ratio (2024 - 2025)
Sky Century Investment (SKYI) posted quarterly Interest Coverage Ratio of 60.28 for Q3 2025, down 85946.56% quarter-over-quarter from 0.07 in Q2 2025.
Sky Century Investment (SKYI) Interest Coverage Ratio (2024 - 2025) Analysis & Trends
Sky Century Investment (SKYI) has reported Interest Coverage Ratio for 2 consecutive years, with 60.28 the latest figure, recorded in Q3 2025.
- In Q3 2025, Interest Coverage Ratio changed N/A year-over-year to 60.28; the TTM figure through May 2026 stood at 105.14 (down 23368.94% YoY), while the FY2025 annual figure was 0.6, down 39.62% from the prior year.
- Interest Coverage Ratio eased to 60.28 in Q3 2025 per SKYI's latest filing, from 0.07 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 0.07 in Q2 2025 and bottomed at 80.15 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -3.15 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 114.07 |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 0.05 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 52.24 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 4.20 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Sky Century Investment | 393,547.71 | 393,283.71 | 26,045.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2025 | -60.28 |
| May 31, 2025 | -0.07 |
| Feb 28, 2025 | -0.15 |
| Nov 30, 2024 | -80.15 |